Customers of the genetic testing company 23andMe have until July 14 to file a claim as part of a restructuring in its bankruptcy case. In filing a claim, eligible customers can seek compensation for ...

If your estate plan was created before the DNA testing era—or hasn't been updated to account for these new realities—now is ...

Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million people, to the drug developer Regeneron Pharmaceuticals for $256 million. The ...

Regeneron Pharmaceuticals announced on Monday that it will acquire "substantially all" of genetic testing company 23andMe's assets. The pharmaceutical company said it won the court-supervised auction ...

Regeneron Pharmaceuticals, a company that has been analyzing genetic data as part of its drug research for more than a decade, is augmenting its capabilities in a big way with the $256 million ...

Following a data breach and bankruptcy, genetic testing service 23andMe will soon be in different hands. On Monday, biotechnology company Regeneron announced that it won the top bid in a bankruptcy ...

Billy Idol was a proud dad to a son and a daughter for most of his life — until he learned in his 60s that he was actually a dad of three. “I really enjoyed being a dad. I always wanted a boy and a ...

If you have a 23andMe account, you have until July 14 to file a claim as part of the restructuring in its bankruptcy case. The filing claim allows eligible customers to seek compensation for financial ...

Today is the deadline for customers of the genetic testing company 23andMe to file a claim as part of a restructuring in its bankruptcy case. In filing a claim, eligible customers can seek ...